Hossein Borghaei, DO, MS
Disclosures: Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-BMS|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Lilly Oncology|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Amgen|Consulting Fee-BMS|Consulting Fee-Lilly Oncology|Consulting Fee-Genentech, Inc.|Consulting Fee-Pfizer, Inc.|Consulting Fee-Merck Merck|Consulting Fee-EMD Serono|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Astra Zeneca Astra Zeneca|Consulting Fee-Novartis Pharmaceuticals|Consulting Fee-Genmab|Consulting Fee-Regeneron|Consulting Fee-Takeda|Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Janssen|Consulting Fee-Natera (Relationship has ended)|Consulting Fee-Pharmamar|Consulting Fee-Guardant|Consulting Fee-Oncocyte (Relationship has ended)|Consulting Fee-Jazz|Consulting Fee-Da Volterra (Relationship has ended)|Consulting Fee-Mirati|Consulting Fee-Puma|Consulting Fee-BerGenBio|Other: DSMB-Incyte|Other: DSMB-Springwork|Other: DSMB-Novartis Pharmaceuticals|Other: DSMB-U of Penn|Stocks or stock options, excluding diversified mutual funds-Sonnetbio|Stocks or stock options, excluding diversified mutual funds-Inspirna|Honoraria-Regeneron (Relationship has ended)|Honoraria-Pfizer, Inc. (Relationship has ended)|Honoraria-Amgen (Relationship has ended)|Honoraria-Daiichi Sankyo, Inc. (Relationship has ended) - 10/01/2024
No Bio Available To display the PDF download directly in your browser, please install the Adobe Acrobat Reader plugin. If you do not want to install the plugin, you can download your file here: Faculty Bio